F. M Kirby Neurobiology Center, Children's Hospital Boston, Boston, MA 02115, USA.
Life Sci. 2013 Mar 19;92(8-9):438-45. doi: 10.1016/j.lfs.2012.06.021. Epub 2012 Jul 4.
G protein coupled receptors (GPCRs) represent the largest family of cell surface receptors that are involved in regulating several physiological and behavioral responses in organisms. Indeed, over half of all the approved drugs on the market target GPCRs. Over the past twenty years, several lines of evidence have suggested that GPCRs associate to form oligomeric structures that substantially expand the complexity of signaling processes in vivo. In addition, GPCRs have also been shown to functionally regulate ion channels and help fine-tune neurotransmission. In this review, we will discuss recent advances in both mechanisms, with specific focus on opioid receptors, cannabinoid receptors and transient receptor potential (TRP) calcium channels in nociception. A better understanding of such mechanisms will be imperative in designing analgesics devoid of deleterious side effects and mitigating drug abuse.
G 蛋白偶联受体 (GPCRs) 是细胞表面受体中最大的家族,参与调节生物体的多种生理和行为反应。事实上,市场上一半以上的批准药物都以 GPCRs 为靶点。在过去的二十年中,有几条证据表明 GPCR 会形成寡聚体结构,从而大大增加体内信号转导过程的复杂性。此外,GPCR 还被证明可以调节离子通道的功能,帮助微调神经递质的传递。在这篇综述中,我们将讨论这两个机制的最新进展,特别关注在痛觉中阿片受体、大麻素受体和瞬时受体电位 (TRP) 钙通道。更好地理解这些机制对于设计没有有害副作用的镇痛药和减轻药物滥用至关重要。